Philip Morris International Inc. (PM)
Philip Morris's stock rises as outlook tops analyst estimates
Tobacco giant cites boost from smokeless products such as the Zyn nicotine pouch.
Philip Morris (PM) Beats Q4 Earnings and Revenue Estimates
Philip Morris (PM) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.36 per share a year ago.
Philip Morris International: The Margin Of Safety Is Not As Wide Anymore
Philip Morris is a leading dividend business with strong smoke-free product growth, including IQOS and ZYN, driving revenue and market share. Despite PM's impressive performance and growth prospects, its EV/EBITDA multiple is nearly double that of peers, reducing the margin of safety. PM's robust dividend policy, with DPS yielding ~4.2% with 17 years of growth, makes it a solid long-term hold despite limited upside potential.
Philip Morris: Fairly Priced Into Earnings, But A Very Strong Chart
I maintain a hold rating on Philip Morris International due to its P/E multiple above 20, despite a strong technical chart. PM's Q3 results were robust, with non-GAAP EPS of $1.91 beating estimates and revenue up 8.4%, driven by price increases and volume growth. Key risks include strong-dollar headwinds, geopolitical tensions, slower smoke-free product growth, and regulatory actions, but PM remains shareholder-friendly with dividends and buybacks.
Philip Morris' Q4 Earnings on Deck: Key Factors to Understand
PM's Q4 results are likely to reflect gains from pricing and smoke-free strength amid volatile currency movements.
Countdown to Philip Morris (PM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Philip Morris (PM) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Philip Morris (PM) Earnings Expected to Grow: Should You Buy?
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How Zyn helped Philip Morris International make a comeback
Philip Morris is investing more than $800 million to expand production in the U.S. as Zyn's popularity soars.
A Once-in-a-Decade Opportunity: Buy This Magnificent Dividend Stock With a 4.2% Yield in 2025 and "Never" Sell
The world is awash in stock market fever. Well, at least a fever centered on artificial intelligence (AI), semiconductors, and cryptocurrency-related investments.
Philip Morris's Zyn nicotine pouch isn't safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company's Zyn nicotine pouches.
Philip Morris Resilient on Smoke-Free Transition Efforts and Pricing
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth amid currency-related challenges.
Philip Morris Continues To Be A Top Dividend Idea Yielding Around 4.5%
Philip Morris (PM) outperformed the S&P 500 in 2024, driven by strong financials, a 4.5% dividend yield, and consistent cash generation exceeding $10 billion annually. Despite regulatory risks, PM's diversified portfolio, including smoke-free products like IQOS and ZYN, positions it for continued revenue and earnings growth in 2025. PM's 16-year dividend growth streak, coupled with a forecasted 20% EPS growth over the next two years, makes it a compelling income investment.
